BridgeMD
New treatment option for Rectal Cancer Recurrent
Official title Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy
ClinicalTrials.gov ID: NCT04695782
What this study is testing
- What it's testing
- Study design: A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer. Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Locally recurrent rectal cancer.
- Bioptically verified (adenocarcinoma )
- Available dose plan from primary radiotherapy
- Previous pelvic RT (\>30Gy EQD2)
- Evaluated in MDT-conferences (Herlev, Aarhus)
You likely can't join if
- Non-resectable distant metastases (PET-CT)
- Unable to undergo MRI, PET-CT
- Inability to attend full course radiotherapy and follow up in the out patient clinic.
See the full eligibility criteria
- Locally recurrent rectal cancer.
- Bioptically verified (adenocarcinoma )
- Available dose plan from primary radiotherapy
- Previous pelvic RT (\>30Gy EQD2)
- Evaluated in MDT-conferences (Herlev, Aarhus)
- Age\>18 years
- PS 0-2
- Adequate organ function
- Informed consent
- Non-resectable distant metastases (PET-CT)
- Unable to undergo MRI, PET-CT
- Inability to attend full course radiotherapy and follow up in the out patient clinic.
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.